Association of post-treatment hypoalbuminemia and survival in Chinese patients with metastatic renal cell carcinoma

Chinese Journal of Cancer
Wen CaiLixin Zhou

Abstract

Hypoalbuminemia adversely affects the clinical outcomes of various cancers. The purpose of this study was to estimate the prognostic value of hypoalbuminemia 3-5 weeks after treatment in patients with metastatic renal cell carcinoma (mRCC) who received sorafenib or sunitinib as first-line treatment. In this single-center, retrospective study, we assessed the progression-free survival (PFS) and overall survival (OS) of 184 mRCC patients who received first-line sorafenib or sunitinib treatment. PFS and OS were compared between patients with post-treatment hypoalbuminemia (post-treatment albumin level <36.4 g/L) and those with normal post-treatment albumin level (albumin level ≥36.4 g/L). The Memorial Sloan Kettering Cancer Center (MSKCC) risk model stratified mRCC patients into three risk categories. Prognostic values of all patient characteristics including MSKCC risk category were determined by using univariate and multivariate Cox regression models. Prognostic value was further determined using the Harrell concordance index and receiver operating characteristic curve analysis. The median PFS and OS of the 184 patients were 11 months (95% confidence interval [CI] 9-12 months) and 23 months (95% CI 19-33 months), respectively. P...Continue Reading

References

Sep 1, 1987·JPEN. Journal of Parenteral and Enteral Nutrition·A S DetskyK N Jeejeebhoy
Jan 1, 1980·American Journal of Surgery·G P BuzbyE F Rosato
Dec 31, 1998·The New England Journal of Medicine·D P KelsenJ A Roth
Jan 5, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerMadhu Mazumdar
Sep 28, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ronald M BukowskiPaul Elson
Mar 23, 2005·Archives of Surgery·Arnaud AlvesUNKNOWN Association Française de Chirurgie
Dec 5, 2006·European Journal of Internal Medicine·Daniel de LuisUNKNOWN Nutrition Group of Society of Cstilla-Leon (Endocrinology, Diabetes and Nutrition)
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marina PartonTim Eisen
Mar 4, 2008·Cancer Treatment Reviews·Kiran GuptaClaudie Charbonneau
Jul 21, 2009·The Lancet Oncology·Martin E GoreRonald Bukowski
Oct 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel Y C HengToni K Choueiri
Mar 27, 2010·Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association·A K GarthT C Crowe
Jun 28, 2011·European Urology·Jean-Jacques PatardJoaquim Bellmunt
Aug 11, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Judith ManolaUNKNOWN International Kidney Cancer Working Group
Jun 19, 2013·Expert Review of Anticancer Therapy·Matteo SantoniMichele Milella
Jan 31, 2014·Medical Oncology·Maria StenmanMagnus Lindskog
Jun 20, 2014·OncoTargets and Therapy·Ding-Wei Ye, Hai-Liang Zhang
Aug 16, 2014·BJU International·Anthony T CorcoranAlexander Kutikov
Jan 27, 2015·European Urology·Borje LjungbergAxel Bex

❮ Previous
Next ❯

Software Mentioned

SPSS
R package “ survival
SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.